<DOC>
	<DOCNO>NCT00316537</DOCNO>
	<brief_summary>The purpose study evaluate safety preliminary efficacy low dose nicotine gel patient chronic diabetic ulcer</brief_summary>
	<brief_title>Safety Preliminary Efficacy Study Nicotine Gel Treat Diabetic Foot Ulcers</brief_title>
	<detailed_description>This pilot study first time nicotine apply directly onto surface chronic diabetic ulcer . The goal study evaluate safety tolerability ( particularly wound site ) gel formulation contain low-dose nicotine , obtain preliminary information effect accelerate wound closure . The study carry background conventional wound therapy patient Type II diabetes mellitus . Patients randomize receive either study medication ( ATG002 ) , vehicle gel , standard-of-care .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Patients diabetes mellitus type II Single nonhealing uninfected partial fullthickness foot ulcer secondary diabetic neuropathy , absence significant peripheral arterial disease . Patients use tobacco form nicotine replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>diabetes</keyword>
	<keyword>foot ulcer</keyword>
	<keyword>nicotine gel</keyword>
	<keyword>wound healing</keyword>
</DOC>